306934-99-6Relevant articles and documents
Thienopyridones as AMPK activators for the treatment of diabetes and obesity
-
Page/Page column 35, (2010/02/10)
The present invention relates to compounds that activate AMP-activated protein kinase (AMPK), including the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, and obesity.
THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS
-
Page 30, (2008/06/13)
The present invention provides thienopyrimidine compounds which are potasium channels inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia are also provided.
Pharmaceutically active compounds and methods of use
-
, (2008/06/13)
New fused thiophene compounds are provided and methods of using those compounds for a variety of therapeutic indications. Compounds of the invention are particularly useful for treatment of neuropathic pain.